Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
Wendy Jeanneret‐Sozzi(Centre Hospitalier Universitaire Vaudois), René‐Olivier Mirimanoff(University of Lausanne), Philip Poortmans(University of Antwerp), Pierre Scalliet, Pauline Gastelblum(Institut Jules Bordet), Marco Krengli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Daniel R. Zwahlen(Kantonsspital Winterthur), Alphonse G. Taghian(Massachusetts General Hospital), Cristina Gutiérrez(Institut Català d'Oncologia), Ron Epelbaum(University of Bern), P. Maingon(Sorbonne Université), S. Villette(Centre Oscar Lambret), Tan Dat Nguyen(Institut Jean Godinot), Mahmut Özsahin(Centre Hospitalier Universitaire Vaudois), Beat Amsler, Rita Abi Raad(Boston University), Yazid Belkacémi(Inserm)
Cited by 163
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k